X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS BIOCON LTD DR. DATSONS LABS/
BIOCON LTD
 
P/E (TTM) x -10.9 36.6 - View Chart
P/BV x 0.2 4.9 3.3% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 DR. DATSONS LABS   BIOCON LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
BIOCON LTD
Mar-16
DR. DATSONS LABS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs126496 25.3%   
Low Rs31397 7.8%   
Sales per share (Unadj.) Rs133.0174.3 76.3%  
Earnings per share (Unadj.) Rs0.244.8 0.3%  
Cash flow per share (Unadj.) Rs6.656.9 11.6%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.8202.8 63.5%  
Shares outstanding (eoy) m31.66200.00 15.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.6 23.0%   
Avg P/E ratio x516.110.0 5,183.8%  
P/CF ratio (eoy) x11.87.8 151.1%  
Price / Book Value ratio x0.62.2 27.6%  
Dividend payout %011.2 0.0%   
Avg Mkt Cap Rs m2,47789,220 2.8%   
No. of employees `000NA4.4 0.0%   
Total wages/salary Rs m566,363 0.9%   
Avg. sales/employee Rs ThNM7,894.5-  
Avg. wages/employee Rs ThNM1,441.2-  
Avg. net profit/employee Rs ThNM2,029.7-  
INCOME DATA
Net Sales Rs m4,21134,854 12.1%  
Other income Rs m79845 9.3%   
Total revenues Rs m4,28935,699 12.0%   
Gross profit Rs m5698,200 6.9%  
Depreciation Rs m2042,423 8.4%   
Interest Rs m430102 421.8%   
Profit before tax Rs m136,520 0.2%   
Minority Interest Rs m0-744 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m62,569 0.2%   
Profit after tax Rs m58,961 0.1%  
Gross profit margin %13.523.5 57.4%  
Effective tax rate %48.039.4 121.9%   
Net profit margin %0.125.7 0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85239,932 17.2%   
Current liabilities Rs m6,71116,276 41.2%   
Net working cap to sales %3.367.9 4.9%  
Current ratio x1.02.5 41.6%  
Inventory Days Days16154 300.3%  
Debtors Days Days31886 369.6%  
Net fixed assets Rs m3,67339,101 9.4%   
Share capital Rs m3171,000 31.7%   
"Free" reserves Rs m3,76138,591 9.7%   
Net worth Rs m4,07840,556 10.1%   
Long term debt Rs m1,67120,724 8.1%   
Total assets Rs m12,63384,816 14.9%  
Interest coverage x1.064.9 1.6%   
Debt to equity ratio x0.40.5 80.2%  
Sales to assets ratio x0.30.4 81.1%   
Return on assets %3.410.7 32.2%  
Return on equity %0.122.1 0.5%  
Return on capital %7.719.0 40.4%  
Exports to sales %22.930.7 74.5%   
Imports to sales %14.320.4 70.1%   
Exports (fob) Rs m96410,717 9.0%   
Imports (cif) Rs m6027,105 8.5%   
Fx inflow Rs m96411,789 8.2%   
Fx outflow Rs m6078,393 7.2%   
Net fx Rs m3573,396 10.5%   
CASH FLOW
From Operations Rs m1,3455,264 25.5%  
From Investments Rs m-2,256-9,540 23.6%  
From Financial Activity Rs m-1,20010,867 -11.0%  
Net Cashflow Rs m-2,1116,591 -32.0%  

Share Holding

Indian Promoters % 4.5 40.4 11.2%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.0 8.4 -  
FIIs % 1.4 10.7 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 19.9 472.9%  
Shareholders   20,807 109,995 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  UNICHEM LAB  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS